Bayesian Simulation Model (MDACC)

Basic Model Attributes
Cancer siteBreast
Host institution University of Texas / M.D. Anderson Cancer Center
Purpose The goal of our model is to provide estimates (and their associated uncertainties) of the relative contributions of screening mammography, hormonal therapy, and improvements in biologic- and chemotherapy to the observed decrease in U.S. breast cancer mortality since 1990. We consider subsets of disease defined by age and tumor characteristics, including stage and hormone receptor and Human Epidermal Growth Factor Receptor 2 (HER2) statuses. We address the potential impact on future U.S. breast cancer mortality of improvements in screening and treatment by disease subtype.
Contact Donald Berry (dberry@mdanderson.org)
ProfileCISNET_ModelProfile_BREAST_MDACC_001_07232013_57428.pdf
Propose changes to this package